Loading organizations...
Axial Biotherapeutics is a clinical stage biopharmaceutical company based in Woburn, Massachusetts, that develops novel small molecule therapeutics targeting the gut-brain axis to treat central nervous system disorders. The enterprise focuses on creating microbiome-inspired treatments for severe neurological conditions, specifically advancing its lead product candidate, AB-2004, into Phase 2b clinical trials for irritability associated with Autism Spectrum Disorder. Operating with an estimated 11 to 50 employees, the biotechnology firm has secured over 81 million dollars in total equity financing across three separate venture rounds to support its clinical pipeline. This capital structure includes a recent Series C financing round backed by prominent institutional investors including Seventure Partners, Longwood Fund, and Domain Associates. The company was originally founded in 2016 by David Donabedian, Sarkis Mazmanian, Westphal, and Aldrich based on research from the California Institute of Technology.
Axial Biotherapeutics has raised $91.4M across 4 funding rounds.
Axial Biotherapeutics has raised $91.4M in total across 4 funding rounds.
Axial Biotherapeutics has raised $91.4M in total across 4 funding rounds.
Axial Biotherapeutics's investors include Sarah Meibusch, Makoto Ohori, Autism Impact Fund, Corundum Systems Biology, Domain Associates, Longwood Fund, Nora Frey, Taiho Ventures, Sakae Asanuma, Isabelle de Cremoux, Heritage Medical Systems, Jim Blair.
Axial Biotherapeutics has raised $91.4M across 4 funding rounds. Most recently, it raised $37.3M Series C in October 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 13, 2021 | $37.3M Series C | Sarah Meibusch, Makoto Ohori | Autism Impact Fund, Corundum Systems Biology, Domain Associates, Longwood Fund, Nora Frey, Taiho Ventures | Announced |
| Jun 20, 2019 | $10M Series B Plus | Sakae Asanuma | — | Announced |
| Feb 27, 2019 | $25M Series B | Isabelle DE Cremoux | Domain Associates, Heritage Medical Systems, Longwood Fund | Announced |
| Nov 30, 2016 | $19.1M Series A | JIM Blair, Michelle Detwiler | Heritage Medical Systems, Kairos Ventures | Announced |
